NCT02496312 (ECOCAPTURE) is a NA clinical trial of Evaluation of Apathy Close to Real Life Situation in Apathy, sponsored by Institut National de la Santé Et de la Recherche Médicale, France.

Who is sponsoring NCT02496312?

NCT02496312 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France.

What drugs are being tested in NCT02496312?

Interventions in NCT02496312: Evaluation of Apathy Close to Real Life Situation.

What condition does NCT02496312 study?

NCT02496312 studies Apathy, Behavior, Frontotemporal Dementia.

Is NCT02496312 still recruiting?

NCT02496312 is currently completed. Last updated 18 November 2025.

Last reviewed 2025-11-18 · How we verify

NCT02496312: ECOCAPTURE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.

Completed NA Last updated 18 November 2025

What this trial tests

NA trial testing Evaluation of Apathy Close to Real Life Situation in Apathy in 14 participants. Completed in 2 October 2015.

Timeline

10 July 2015

Primary endpoint
2 October 2015

2 October 2015

Quick facts

Lead sponsor	Institut National de la Santé Et de la Recherche Médicale, France
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	14
Start date	10 July 2015
Primary completion	2 October 2015
Estimated completion	2 October 2015

Drugs / interventions tested

Evaluation of Apathy Close to Real Life Situation

Conditions studied

Apathy — all drugs for Apathy →
Behavior — all drugs for Behavior →
Frontotemporal Dementia — all drugs for Frontotemporal Dementia →

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France — full company profile →

Who can join

Adults 20 to 85, any sex, with Apathy or Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to provide relevant quantitative evaluation of apathy close to real life situation by means of a multimodal sensor system integrated.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Use of nonintrusive sensor-based information and communication technology for real-world evidence for clinical trials in dementia.
Teipel S, König A, Hoey J, Kaye J, et al · · 2018 · cited 35× · PMID 29936147 · DOI 10.1016/j.jalz.2018.05.003
Functional connectivity correlates of reduced goal-directed behaviors in behavioural variant frontotemporal dementia.
Godefroy V, Batrancourt B, Charron S, Bouzigues A, et al · · 2022 · cited 16× · PMID 35751676 · DOI 10.1007/s00429-022-02519-5
Exploration Deficits Under Ecological Conditions as a Marker of Apathy in Frontotemporal Dementia.
Batrancourt B, Lecouturier K, Ferrand-Verdejo J, Guillemot V, et al · · 2019 · cited 14× · PMID 31551908 · DOI 10.3389/fneur.2019.00941
Disentangling Clinical Profiles of Apathy in Behavioral Variant Frontotemporal Dementia.
Godefroy V, Batrancourt B, Charron S, Bouzigues A, et al · · 2022 · cited 7× · PMID 36155506 · DOI 10.3233/jad-220370

Verify or expand the search:

Other recruiting trials for Apathy

Currently open trials in the same condition.

NCT05877885 — Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics · NA · recruiting
NCT06919094 — A Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults · NA · recruiting
NCT07113067 — Accelerated rTMS vs. Sham for Stroke Apathy · Phase 1, PHASE2 · recruiting
NCT07118956 — Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease · NA · recruiting
NCT05232877 — Effects of t-DCS and Cognitive Training on Apathy in Elderly With Minor Neurocognitive Impairment · NA · active not recruiting

Other Institut National de la Santé Et de la Recherche Médicale, France trials

Trials by the same sponsor.

NCT07311213 — GENES AND AUTISM - IPSC · NA · not yet recruiting
NCT07063719 — Identification of Cellular Biomarkers of Rare Eye Diseases in Adults · NA · not yet recruiting
NCT06906042 — Multimodal Cardiovascular and Hepatic Population Imaging · recruiting
NCT06951035 — Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke · NA · not yet recruiting
NCT06660108 — MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02496312 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut National de la Santé Et de la Recherche Médicale, France
Last refreshed: 18 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02496312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing